• Policy
• Yoon Gov should increase bio-health investment by 15% per yr
• by Lee, Jeong-Hwan Jun 14, 2022 06:04am

• Policy
• A petition has been filed for public consent to Enhurtu
• by Lee, Jeong-Hwan Jun 13, 2022 05:55am

• InterView
• Otrivin package made user-friendly for pharmacist & patient
• by Eo, Yun-Ho Jun 13, 2022 05:55am

• Product
• Prescription of oral COVID-19 drugs drop to 1,800 last week
• by Kang, Shin-Kook Jun 13, 2022 05:54am

• Policy
• Novartis' new adult leukemia drug Scemblix has been approved
• by Lee, Hye-Kyung Jun 13, 2022 05:54am

• Policy
• The risk group for COVID-19 depression was 18.5%, down
• by Lee, Jeong-Hwan Jun 13, 2022 05:54am

• Company
• Hanall Biopharma to expand HL161 development in earnest
• by Chon, Seung-Hyun Jun 10, 2022 05:44am

• Company
• Exports of CKD·Dong-A ST's antianemic biosimilars increase
• by Chon, Seung-Hyun Jun 10, 2022 05:43am

• Company
• Sanofi & 4 other companies will participate in NIP
• by Lee, Tak-Sun Jun 10, 2022 05:42am

• Company
• Hanmi’s new biologic receives orphan designation in Europe
• by Chon, Seung-Hyun Jun 10, 2022 05:42am